Tempus AI (TEM) to Release Earnings on Tuesday

Tempus AI (NASDAQ:TEM - Get Free Report) is projected to issue its Q1 2025 quarterly earnings data after the market closes on Tuesday, May 6th. Analysts expect the company to announce earnings of ($0.27) per share and revenue of $248.13 million for the quarter.

Tempus AI Trading Up 0.7 %

NASDAQ TEM traded up $0.37 on Tuesday, hitting $54.14. The company's stock had a trading volume of 6,798,721 shares, compared to its average volume of 5,679,362. The company's 50-day moving average is $49.28 and its 200 day moving average is $50.52. The company has a current ratio of 2.69, a quick ratio of 2.55 and a debt-to-equity ratio of 8.17. Tempus AI has a 1-year low of $22.89 and a 1-year high of $91.45.

Analyst Ratings Changes

A number of analysts have commented on TEM shares. TD Cowen restated a "buy" rating and set a $74.00 price target (up previously from $58.00) on shares of Tempus AI in a research note on Wednesday, February 5th. Needham & Company LLC restated a "buy" rating and issued a $70.00 target price on shares of Tempus AI in a report on Thursday, April 24th. Guggenheim reissued a "buy" rating on shares of Tempus AI in a report on Tuesday, February 25th. Wolfe Research lowered Tempus AI from a "strong-buy" rating to a "hold" rating in a report on Wednesday, February 26th. Finally, BTIG Research initiated coverage on Tempus AI in a report on Monday, April 21st. They set a "buy" rating and a $60.00 price target for the company. Six equities research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and a consensus price target of $61.08.

Insider Buying and Selling at Tempus AI

In other news, CAO Ryan M. Bartolucci sold 13,770 shares of Tempus AI stock in a transaction dated Friday, January 31st. The stock was sold at an average price of $60.00, for a total transaction of $826,200.00. Following the transaction, the chief accounting officer now directly owns 57,237 shares of the company's stock, valued at $3,434,220. The trade was a 19.39 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Wayne A.I. Frederick sold 3,000 shares of the company's stock in a transaction on Monday, March 31st. The stock was sold at an average price of $45.54, for a total transaction of $136,620.00. Following the completion of the transaction, the director now directly owns 26,514 shares of the company's stock, valued at $1,207,447.56. This represents a 10.16 % decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders have sold 4,584,252 shares of company stock worth $272,870,580. Insiders own 27.60% of the company's stock.

Tempus AI Company Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.